No definition available.
Chronic myeloid leukaemia, excluding all cancers (controls excluding all cancers)
C3_CML_EXALLC
Endpoint definition
↥
Endpoint definition steps |
FinnGen |
|---|---|
Phenotype data |
520210 |
1. Apply sex-specific ruleNone |
520210 |
2. Check conditionsNone |
520210 |
3. Check pre-conditions, main-only, mode, registry filtersRegistry filters:
3 out of 7 registries used, show all original rules. |
319 |
4. Check minimum number of eventsNone |
319 |
5. Include endpointsNone |
319 |
6. Filter based on genotype QC (FinnGen only) |
319 |
Control definitions (FinnGen only)
- Control exclude
- C3_CANCER, C3_CANCER_WIDE_EXALLC
Extra metadata
- First used in FinnGen datafreeze
- DF12
Chronic myeloid leukaemia, excluding all cancers (controls excluding all cancers)
based on the number of shared cases.
Similar with more cases:
Similar with less cases:
Summary Statistics
↥-FinRegistry-
This endpoint is excluded (different definition than used in FinnGen).
-FinnGen-
Key figures
| All | Female | Male | |
|---|---|---|---|
| Number of individuals | 319 | 145 | 174 |
| Unadjusted period prevalence (%) | 0.06 | 0.05 | 0.08 |
| Median age at first event (years) | 58.32 | 57.50 | 59.01 |
-FinnGen-
Age distribution of first events
-FinnGen-
Year distribution of first events
-FinnGen-
Cumulative Incidence Function
CodeWAS (R11)
↥CodeWAS is a tool for exploring the associations between an endpoint and all of the medical codes and drug codes.
This is a new tool, please reach out using the contact form for feedback and improvement ideas.
First, a cohort is built by matching controls to the endpoint cases using year of birth and sex. Then, a Fisher test is done for all the medical codes and drug codes between the cases and controls of this cohort. Codes are reported in the table below if they have −log10(p-value) ≥ 6.
Matched cohort
- Matched cases
- 142
- Matched controls
- 1419
Code
Vocabulary
Description
Odds Ratio
-log10(p)
N matched cases
N matched controls
C92.1
ICD-10 Finland
Chronic myeloid leukaemia [CML], BCR/ABL-positive
+∞
202.0
141
*
117
Kela drug reimbursment
Leukaemia and other malignant diseases of the blood and bone marrow, and malignant diseases of the lymphatic tissue
3516.3
175.5
135
7
9863/3-C42.1
ICD-O-3
Chronic myeloid leukemia, NOS, of bone marrow
+∞
164.2
124
*
189
Kela drug reimbursment
Imatinib
+∞
131.5
105
*
L01XE01
ATC
[U] imatinib; oral
+∞
105.9
88
*
XW000
NOMESCO Finland
Bone marrow biopsy
88.6
70.6
76
18
M04AA01
ATC
allopurinol; systemic
26.6
61.2
98
109
L01XX05
ATC
hydroxycarbamide; oral
156.4
56.9
57
6
L01EA01
ATC
imatinib; oral (bcr-abl tyrosine kinase inhibitors)
+∞
51.2
46
*
316
Kela drug reimbursment
Imatinib
+∞
46.4
42
*
152
Kela drug reimbursment
Nilotinib
+∞
39.4
36
*
D72.8
ICD-10 Finland
Other specified disorders of white blood cells
119.2
34.6
36
*
L01XX28
ATC
[D] imatinib; oral
+∞
33.7
31
*
C92.0
ICD-10 Finland
Acute myeloblastic leukaemia [AML]
+∞
33.7
31
*
L01XE08
ATC
[U] nilotinib; oral
+∞
28.0
26
*
150
Kela drug reimbursment
Dasatinib
+∞
28.0
26
*
L03AA02
ATC
filgrastim; parenteral
+∞
25.8
24
*
212
Kela drug reimbursment
Gout
51.4
24.7
29
7
L01XE06
ATC
[U] dasatinib; systemic
+∞
24.7
23
*
C91.1
ICD-10 Finland
Chronic lymphocytic leukaemia of B-cell type
+∞
22.5
21
*
328
Kela drug reimbursment
Nilotinib
+∞
20.3
19
*
L01EA03
ATC
nilotinib; oral
+∞
20.3
19
*
127
Kela drug reimbursment
Transplant complication
42.9
18.2
22
6
324
Kela drug reimbursment
Dasatinib
+∞
18.1
17
*
L01EA02
ATC
dasatinib; oral
+∞
18.1
17
*
9875/3-C42.1
ICD-O-3
Chronic myelogenous leukemia, BCR/ABL positive of bone marrow
+∞
18.1
17
*
A05AA02
ATC
ursodeoxycholic acid; oral
51.3
12.1
14
*
TNE25
NOMESCO Finland
Drill biopsy of bone marrow, pelvis
38.5
11.5
14
*
L04AA01
ATC
[U] ciclosporin; systemic
27.7
11.4
15
6
D75.9
ICD-10 Finland
Disease of blood and blood-forming organs, unspecified
118.3
10.6
11
*
T86.0
ICD-10 Finland
Bone-marrow transplant rejection
+∞
10.5
10
*
121
Kela drug reimbursment
Severe hypofunction of sexual glands
43.4
10.1
12
*
WW500
NOMESCO Finland
Blood transfusion
14.8
9.9
16
12
D72.9
ICD-10 Finland
Disorder of white blood cells, unspecified
59.1
9.8
11
*
C61
ICD-10 Finland
Malignant neoplasm of prostate
+∞
9.5
9
*
C95.0
ICD-10 Finland
Acute leukaemia of unspecified cell type
+∞
9.5
9
*
L03AA04
ATC
NA
+∞
9.5
9
*
R50.9
ICD-10 Finland
Fever, unspecified
4.2
9.4
38
113
Y84
ICD-10 Finland
Other medical procedures as the cause of abnormal reaction of the patient, or of later complication, without mention of misadventure at the time of the procedure
39.4
9.2
11
*
WW200
NOMESCO Finland
Immunization
11.8
9.0
16
15
C44.31
ICD-10 Finland
Basocellular carcinoma of the skin on another or unspecified part of the face
95.4
8.5
9
*
GD1AA
NOMESCO Finland
Thorax X-ray examination
2.9
8.4
74
388
C92.9
ICD-10 Finland
Myeloid leukaemia, unspecified
+∞
8.4
8
*
170
Kela drug reimbursment
Bosutinib
+∞
8.4
8
*
8140/3-C61.9
ICD-O-3
Adenocarcinoma, NOS, of prostate gland
+∞
8.4
8
*
NEA10
NOMESCO Finland
Exploration of soft tissue of pelvis, percutaneous
+∞
8.4
8
*
JN1AE
NOMESCO Finland
Ultrasound examination of upper part of abdomen
5.7
7.8
22
44
JN3AE
NOMESCO Finland
Abdominal ultrasound examination
4.1
7.7
31
91
B25.8
ICD-10 Finland
Other cytomegaloviral diseases
84.2
7.5
8
*
WD105
NOMESCO Finland
Cystostatic therapy of methastized malignancy
+∞
7.3
7
*
J01EE01
ATC
sulfamethoxazole and trimethoprim; systemic
5.8
7.3
20
39
FM1AE
NOMESCO Finland
Standard cardiac ultrasound examination
3.3
6.9
38
143
C03CA01
ATC
furosemide; systemic
2.8
6.8
55
265
A03FA01
ATC
metoclopramide; systemic, rectal
3.9
6.5
27
81
A01AB04
ATC
amphotericin B; local oral
6.3
6.4
16
28
B73
ICPC
Leukaemia
+∞
6.3
6
*
2051A
ICD-9 Finland
Myeloid leukaemia, Chronic
+∞
6.3
6
*
8090/3-C44.3
ICD-O-3
Basal cell carcinoma, NOS, of skin of other and unspecified parts of face
+∞
6.3
6
*
ZX090
NOMESCO Finland
Other technic of radiotherapy
+∞
6.3
6
*
J05AB11
ATC
valaciclovir; oral
3.7
6.2
27
85
B99
ICD-10 Finland
Other and unspecified infectious diseases
13.3
6.2
10
8
TQX10
NOMESCO Finland
Biopsy of skin and subcutaneous tissue
4.7
6.1
20
48
A12AX
ATC
Calcium, combinations with vitamin D and/or other drugs
2.7
6.0
49
233
LabWAS
↥OMOP Concept
People with measurements
Mean N measurements
Mean measured value
(ID) Name
N Cases
N Controls
OR
-log10(p)
cases
controls
cases
controls
unit
-log10(p)
N cases
N controls
146
219
11.45
102.79
4.5
2.3
68.2
67.3
e9/l
0.09
111
173
89
0
+∞
98.10
15.7
0.0
—
—
—
0
0
87
0
+∞
95.76
11.7
0.0
—
—
—
0
0
185
679
5.11
46.55
6.7
2.3
341.0
8643.8
umol/l
3.57
177
599
267
1347
7.03
44.49
29.3
6.2
3.6
4.3
e9/l
4.18
257
1187
60
100
7.16
35.98
1.8
2.0
1.3
1.4
g/l
0.68
53
87
232
1180
4.54
34.31
14.9
5.4
1.2
1.2
mmol/l
0.43
204
1017
35
33
11.79
32.78
1.1
1.2
138.3
110.4
u/ml
—
9
5
35
36
10.80
30.88
2.5
1.4
—
—
—
0
0
41
53
8.73
30.49
1.7
2.0
—
—
—
0
0
35
39
9.96
29.13
2.3
1.4
—
—
—
0
0
210
1071
3.81
29.12
13.4
4.7
1.2
1.2
mmol/l
0.18
202
956
28
25
12.18
27.04
2.3
1.9
33.6
34.1
pg
0.19
28
25
96
306
4.06
26.79
3.2
2.4
22.8
23.2
%
0.12
83
265
31
36
9.43
24.94
6.6
3.8
53.2
58.1
%
0.94
31
36
20
12
17.71
23.92
4.1
2.0
726.7
835.4
e6/l
—
7
5
28
35
8.67
21.22
6.5
3.3
3.0
4.5
e9/l
2.32
28
35
25
27
9.96
21.14
2.5
1.4
—
—
—
0
0
21
18
12.42
20.66
8.3
2.7
46.8
50.3
%
0.15
13
12
91
362
3.12
17.24
2.8
1.7
—
—
—
0
0
27
43
6.77
16.56
1.1
1.1
—
—
—
0
0
20
5
42.53
16.53
4.1
2.0
—
—
—
0
0
20
23
9.21
16.06
1.6
1.4
—
—
—
0
0
124
603
2.73
16.05
2.8
2.1
2.8
3.0
mg/l
0.36
114
510
149
797
2.63
15.88
3.3
2.3
58.0
57.6
u/l
0.05
144
734
225
1475
2.78
15.69
8.4
4.0
6.8
6.7
mmol/l
0.04
219
1371
25
39
6.87
15.61
1.1
1.2
352.1
232.6
u/ml
0.95
19
22
23
33
7.43
15.47
1.8
1.4
—
—
—
0
0
174
1034
2.50
14.45
8.5
3.5
—
—
—
0
0
172
1024
2.47
14.13
4.3
2.6
264.0
131.5
ug/l
3.30
166
945
49
151
3.65
13.80
1.8
1.5
—
—
—
0
0
150
853
2.43
13.46
4.3
3.0
—
—
—
0
0
17
20
8.92
13.37
2.6
1.2
—
—
—
0
0
67
256
3.05
13.34
2.5
1.8
—
—
—
0
0
19
26
7.71
13.26
2.0
1.5
—
—
—
0
0
67
261
2.98
12.87
2.4
1.8
—
—
—
0
0
15
16
9.79
12.64
2.8
1.1
—
—
—
0
0
15
16
9.79
12.64
2.8
1.1
—
—
—
0
0
15
16
9.79
12.64
2.8
1.1
—
—
—
0
0
13
12
11.25
12.03
1.0
1.2
—
—
—
0
0
17
24
7.43
11.53
2.6
1.2
—
—
—
0
0
32
83
4.17
11.41
2.6
1.7
1.9
2.1
ug/l
0.06
32
76
27
63
4.59
10.99
1.7
1.2
—
—
—
0
0
25
55
4.85
10.91
1.4
1.3
—
—
—
0
0
30
77
4.20
10.84
2.4
3.5
—
—
—
0
0
16
23
7.27
10.67
1.9
1.6
—
—
—
0
0
131
760
2.23
10.62
6.7
2.0
2.3
2.4
mmol/l
2.41
125
634
14
18
8.09
10.22
1.9
1.6
—
—
—
0
0
20
39
5.40
9.97
1.1
1.0
—
—
—
0
0
135
812
2.15
9.82
6.6
2.8
39.7
33.5
u/l
0.44
129
769
11
11
10.32
9.59
1.6
1.9
—
—
—
0
0
11
11
10.32
9.59
1.6
1.9
—
—
—
0
0
15
24
6.51
9.07
2.0
1.4
—
—
—
0
0
13
18
7.49
8.91
3.2
1.7
—
—
—
0
0
14
22
6.61
8.60
1.6
1.5
—
—
—
0
0
12
16
7.75
8.47
1.8
1.1
20620.5
20495.3
e6/l
—
6
10
8
0
+∞
8.37
1.0
0.0
—
—
—
0
0
93
518
2.12
7.98
6.0
1.9
—
—
—
0
0
93
536
2.04
7.19
1.9
1.7
1.6
1.0
mg/l
1.06
76
406
18
44
4.28
6.91
1.9
1.3
—
—
—
0
0
57
277
2.29
6.77
9.5
5.7
12.2
11.6
kpa
0.48
52
267
21
59
3.74
6.71
1.4
1.3
—
1.1
—
0
6
56
277
2.24
6.37
9.6
5.7
1.1
1.6
mmol/l
0.31
39
218
12
22
5.63
6.33
1.0
1.0
—
—
—
0
0
87
514
1.95
6.17
1.8
1.8
1253.1
1159.2
nmol/l
0.41
81
391
102
636
1.89
6.15
1.9
1.5
20.2
21.3
nmol/l
0.30
93
543
10
8
12.85
6.12
1.8
3.3
—
—
—
0
0
37
159
2.50
5.75
3.7
3.6
0.3
2.0
mmol/l
1.34
25
114
12
25
4.95
5.54
1.7
1.1
—
—
—
0
0
34
144
2.52
5.45
1.9
1.7
—
—
—
0
0
8
5
16.35
5.43
3.6
1.0
—
—
—
0
0
8
5
16.35
5.43
3.8
1.0
—
—
—
0
0
8
5
16.35
5.43
3.8
1.0
—
—
—
0
0
5
0
+∞
5.22
1.4
0.0
—
—
—
0
0
9
9
10.25
5.05
3.6
1.1
—
—
—
0
0
9
9
10.25
5.05
3.6
1.1
—
—
—
0
0
9
9
10.25
5.05
3.6
1.1
—
—
—
0
0
9
9
10.25
5.05
3.6
1.1
—
—
—
0
0
8
7
11.68
4.81
1.3
1.1
—
—
—
0
0
8
7
11.68
4.81
1.3
1.1
—
—
—
0
0
7
5
14.27
4.59
1.0
1.0
—
—
—
0
0
7
5
14.27
4.59
7.6
1.0
—
—
—
0
0
24
95
2.65
4.41
1.4
1.2
8.4
10.5
g/l
2.08
16
80
148
1107
1.63
4.37
2.3
2.0
92.1
95.2
pmol/l
0.32
103
555
24
96
2.62
4.32
1.5
1.3
3.3
3.1
g/l
0.46
15
74
17
56
3.15
4.31
2.3
1.3
—
—
—
0
0
229
1914
1.70
4.30
6.1
4.0
14.1
11.4
mm/h
1.95
222
1756
7
6
11.89
4.29
1.3
1.2
—
—
—
0
0
7
6
11.89
4.29
1.3
1.2
—
—
—
0
0
137
1009
1.63
4.28
3.7
3.6
24.6
75.9
ng/l
0.86
111
712
16
51
3.25
4.27
1.8
2.1
129.4
132.5
g/l
—
10
36
25
103
2.55
4.25
1.5
1.3
7.1
7.5
g/l
0.37
15
77
25
103
2.55
4.25
1.5
1.3
—
—
—
0
0
25
103
2.55
4.25
1.5
1.3
3.6
3.8
g/l
0.38
15
73
32
150
2.26
4.13
1.7
1.4
—
—
—
0
0
98
672
1.66
4.02
4.6
2.8
0.6
0.4
e6/l
0.22
86
488
53
304
1.89
4.01
13.8
5.0
104.0
104.2
mmol/l
0.05
53
297
71
447
1.76
3.97
4.2
2.0
2.4
2.4
mmol/l
0.11
71
382
21
86
2.54
3.63
3.6
1.5
—
—
—
0
0
43
238
1.93
3.61
5.5
3.2
2.5
2.3
mmol/l
0.10
35
194
60
378
1.72
3.33
4.7
2.8
2.3
2.6
e6/l
0.14
39
193
12
38
3.24
3.24
1.3
1.4
—
—
—
0
0
12
38
3.24
3.24
1.3
1.4
—
—
—
0
0
(3020427) Coagulation factor X inhibitor [Units/volume] in Platelet poor plasma by Coagulation assay
17
68
2.58
3.09
2.9
2.2
0.3
0.4
u/ml
0.10
12
32
7
12
5.94
3.03
1.4
1.0
—
—
—
0
0
23
110
2.18
2.86
4.4
4.1
24.3
25.0
mmol/l
0.39
23
104
11
36
3.13
2.83
1.1
1.4
—
—
—
0
0
11
36
3.13
2.83
1.2
1.7
—
—
—
0
0
19
84
2.34
2.83
2.3
1.5
—
—
—
0
0
11
37
3.04
2.72
1.4
2.4
59331.6
6730.4
u/l
—
5
14
6
10
6.09
2.71
1.0
1.1
—
—
—
0
0
150
1223
1.43
2.53
3.8
3.6
0.0
0.0
estimate
0.00
25
196
11
40
2.81
2.40
1.2
1.1
—
—
—
0
0
13
52
2.56
2.39
1.3
1.2
—
—
—
0
0
147
1209
1.40
2.29
5.0
4.9
0.0
0.0
estimate
0.00
30
200
9
29
3.16
2.24
1.3
1.1
—
—
—
0
0
8
24
3.39
2.19
1.1
1.6
—
—
—
0
0
9
30
3.06
2.16
1.3
1.1
—
—
—
0
0
9
30
3.06
2.16
1.3
1.1
—
—
—
0
0
9
30
3.06
2.16
1.3
1.1
—
—
—
0
0
9
30
3.06
2.16
1.3
1.1
—
—
—
0
0
9
30
3.06
2.16
1.3
1.1
—
—
—
0
0
5
10
5.06
2.08
1.0
1.5
—
—
—
0
0
274
2539
1.56
2.05
36.9
12.0
19.7
23.0
mg/l
0.90
250
1936
6
15
4.06
2.05
1.7
2.6
991.7
672.8
u/ml
—
6
15
144
1203
1.36
1.96
3.7
3.5
0.0
0.0
estimate
0.00
28
203
15
71
2.17
1.95
1.3
1.4
—
—
—
0
0
34
213
1.67
1.95
4.1
2.8
—
—
—
0
0
5
11
4.60
1.95
17.4
1.4
189.6
218.2
u/l
—
5
11
231
2081
1.40
1.93
47.8
14.3
14.7
13.6
%
20.57
231
2038
19
100
1.96
1.90
1.4
1.9
—
151.4
—
0
7
5
12
4.21
1.83
3.4
1.1
—
—
—
0
0
70
524
1.43
1.82
6.0
3.8
131.0
319.3
ng/l
0.90
60
414
6
19
3.20
1.67
1.7
1.1
—
—
—
0
0
213
1916
1.34
1.64
4.1
3.7
15.1
14.8
pmol/l
0.66
205
1724
31
199
1.62
1.64
4.2
2.1
57.2
64.5
ml/min/173m2
0.75
21
81
170
1482
1.31
1.64
2.7
2.8
—
—
—
0
0
6
20
3.04
1.59
1.0
1.1
—
—
—
0
0
56
419
1.41
1.46
3.9
2.6
1.5
1.2
e6/l
0.34
37
232
5
16
3.16
1.44
1.0
1.4
15.2
16.7
ug/l
—
5
16
81
657
1.31
1.27
4.1
3.7
0.0
0.0
estimate
0.50
25
199
6
26
2.33
1.19
1.0
1.1
—
—
—
0
0
14
81
1.76
1.11
2.5
3.4
4.0
3.9
mmol/l
0.11
14
75
7
33
2.15
1.06
1.0
1.6
—
—
—
0
0
111
962
1.24
1.01
4.0
3.6
—
—
—
0
0
71
584
1.28
1.01
4.1
3.7
1.0
1.0
kg/l
2.44
14
88
65
529
1.29
1.00
1.5
1.7
508.0
13380717.6
pmol/l
0.50
52
426
5
23
2.19
0.98
1.2
1.0
—
—
—
0
0
20
133
1.54
0.97
2.6
2.2
0.6
0.7
%
0.21
20
133
19
126
1.54
0.93
1.2
1.3
—
—
—
0
0
11
64
1.74
0.87
2.8
1.7
174.9
259.1
pmol/l
1.99
11
59
8
45
1.80
0.85
1.4
1.4
—
—
—
0
0
6
31
1.95
0.85
1.7
1.3
—
—
—
0
0
0
27
0.00
0.78
0.0
1.2
—
—
—
0
0
6
34
1.78
0.76
1.3
1.4
68.5
65.3
pmol/l
—
6
34
13
83
1.59
0.76
1.2
1.2
—
—
—
0
0
13
83
1.59
0.76
1.2
1.2
—
—
—
0
0
5
26
1.94
0.71
2.8
4.7
—
—
—
0
0
5
28
1.80
0.66
1.0
1.1
—
—
—
0
0
249
2389
1.19
0.62
31.8
10.8
74.1
79.6
ml/min/173m2
3.11
229
1916
16
220
0.71
0.61
1.7
1.8
—
—
—
0
0
0
21
0.00
0.60
0.0
1.6
—
—
—
0
0
8
123
0.64
0.56
1.0
1.0
—
—
—
0
0
180
1700
1.13
0.51
3.4
3.1
61.5
47.8
u/l
0.85
170
1591
42
356
1.21
0.49
23.1
24.6
1.2
1.3
inr
—
6
55
241
2324
1.15
0.48
5.1
4.5
1.9
2.4
mu/l
0.53
232
2110
255
2473
1.16
0.45
5.0
4.1
1.6
1.3
mmol/l
1.51
246
2263
12
87
1.39
0.43
2.3
1.5
—
—
—
0
0
5
33
1.52
0.41
1.4
1.2
—
1.2
—
0
11
279
2846
0.84
0.41
55.1
17.8
4.0
4.5
e12/l
28.68
274
2760
39
338
1.18
0.37
10.7
6.6
—
—
—
0
0
73
669
1.12
0.33
1.7
1.7
2.1
1.4
mmol/l
1.06
65
555
6
47
1.28
0.32
1.2
1.5
—
—
—
0
0
21
174
1.22
0.32
1.6
1.3
—
36.2
—
0
10
35
307
1.16
0.30
1.5
1.8
1.4
1.6
%
0.70
28
277
73
786
0.91
0.28
3.6
3.5
23.8
24.4
%
0.14
37
345
50
546
0.90
0.25
2.4
2.5
0.7
0.7
ug/l
0.01
31
352
7
92
0.76
0.23
2.3
2.0
—
—
—
0
0
0
11
0.00
0.21
0.0
1.2
—
—
—
0
0
0
11
0.00
0.21
0.0
1.2
—
—
—
0
0
0
11
0.00
0.21
0.0
1.2
—
—
—
0
0
0
11
0.00
0.21
0.0
1.2
—
243.2
—
0
6
0
11
0.00
0.21
0.0
1.2
—
—
—
0
0
0
10
0.00
0.21
0.0
1.1
—
—
—
0
0
0
12
0.00
0.21
0.0
1.0
—
—
—
0
0
0
12
0.00
0.21
0.0
1.2
—
9.1
—
0
12
0
12
0.00
0.21
0.0
2.2
—
—
—
0
0
49
453
1.10
0.20
1.2
1.3
1.3
12.7
u/ml
3.13
17
170
6
51
1.18
0.19
1.2
1.1
—
—
—
0
0
50
464
1.09
0.19
1.2
1.3
17.1
33.3
iu/ml
1.65
16
146
259
2625
0.93
0.17
5.7
5.1
2.5
2.7
mmol/l
4.81
251
2420
8
71
1.13
0.16
2.0
1.9
—
—
—
0
0
18
203
0.88
0.15
1.5
2.1
—
—
—
0
0
16
182
0.87
0.15
1.4
1.9
—
—
—
0
0
250
2526
0.95
0.10
5.4
4.6
6.1
6.0
mmol/l
0.83
236
2294
7
64
1.10
0.08
1.1
1.2
—
2.9
—
0
6
100
984
1.02
0.04
4.2
3.7
7.4
1.9
ug/l
0.48
92
879
41
399
1.03
0.03
1.7
1.5
—
—
—
0
0
10
92
1.09
0.03
2.0
2.7
—
—
—
0
0
243
2419
1.02
0.02
6.3
6.1
39.1
40.3
mmol/mol
1.67
231
2256
231
2319
0.99
0.01
38.8
13.0
36.9
40.4
%
5.77
153
1629
30
302
0.99
0.00
1.6
1.4
—
—
—
0
0
257
2571
1.00
0.00
5.4
4.6
4.3
4.6
mmol/l
4.64
252
2377
255
2553
0.99
0.00
5.2
4.5
1.3
1.5
mmol/l
6.73
247
2351
53
533
0.99
0.00
1.2
1.2
1.0
1.8
u/ml
—
9
142
16
156
1.03
0.00
1.2
1.3
30.7
118.3
iu/ml
—
6
63
5
58
0.86
0.00
1.2
1.3
—
—
—
0
0
0
6
0.00
0.00
0.0
1.0
—
—
—
0
0
0
6
0.00
0.00
0.0
1.0
—
—
—
0
0
0
9
0.00
0.00
0.0
1.0
—
1378.4
—
0
9
0
9
0.00
0.00
0.0
1.2
—
—
—
0
0
0
9
0.00
0.00
0.0
1.0
—
—
—
0
0
0
6
0.00
0.00
0.0
1.0
—
—
—
0
0
7
76
0.92
0.00
1.1
1.2
—
9.8
—
0
12
0
6
0.00
0.00
0.0
1.3
—
—
—
0
0
0
6
0.00
0.00
0.0
1.3
—
—
—
0
0
0
5
0.00
0.00
0.0
1.4
—
—
—
0
0
0
5
0.00
0.00
0.0
1.4
—
—
—
0
0
0
6
0.00
0.00
0.0
1.0
—
—
—
0
0
0
6
0.00
0.00
0.0
1.0
—
—
—
0
0
5
52
0.96
0.00
1.0
1.4
—
—
—
0
0
0
8
0.00
0.00
0.0
2.1
—
—
—
0
0
0
8
0.00
0.00
0.0
2.1
—
—
—
0
0
0
6
0.00
0.00
0.0
1.0
—
—
—
0
0
7
69
1.01
0.00
1.1
1.2
—
—
—
0
0
0
6
0.00
0.00
0.0
1.0
—
—
—
0
0
0
8
0.00
0.00
0.0
1.1
—
—
—
0
0
0
7
0.00
0.00
0.0
1.3
—
—
—
0
0
6
65
0.92
0.00
1.0
1.2
—
42.1
—
0
7
6
68
0.88
0.00
1.0
1.2
—
—
—
0
0
Mortality – FinRegistry
↥This endpoint is excluded (different definition than used in FinnGen).
Relationships between endpoints
↥Index endpoint: C3_CML_EXALLC – Chronic myeloid leukaemia, excluding all cancers (controls excluding all cancers)
GWS hits: 1
This endpoint is excluded (different definition than used in FinnGen).